search img
Stevanato Group announces product development collaboration with Cambridge Design Partnership on pen-injector technology - Stevanato Group
Home - Integrated solutions for pharma & healthcare - Stevanato Group > News & Events - Stevanato Group > Press Releases - Stevanato Group > Stevanato Group announces product development collaboration with Cambridge Design Partnership on pen-injector technology - Stevanato Group

April, 28 2020

Stevanato Group announces product development collaboration with
Cambridge Design Partnership on pen-injector technology

Piombino Dese (PD), April 28th, 2020 - Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and Cambridge Design Partnership (CDP), a UK- and US-based leading technology and product design partner, today announced a collaboration agreement for the development of a new pen-injector based on the Axis-D technology and intellectual property (IP) licensed exclusively from Haselmeier in 2019.

The collaboration between CDP and Stevanato Group strongly supports Stevanato Group’s portfolio expansion of devices for patients suffering from diabetes.

The agreement leverages the mutual strengths: on one side, CDP’s leading design and development expertise in drug delivery devices and on the other, Stevanato Group’s extensive experience in glass containers, tooling, injection molding, device assembly, and its global commercial network.  

CDP and Stevanato Group will be able to offer innovative drug delivery solutions to pharmaceutical customers working together from the first concept right through design development, scale-up, regulatory submission, and commercial-scale production in all global markets.

“Our R&D team - with the active support of CDP, an established player in the design and development of drug delivery devices - will offer a competitive pen-injector platform and some customization options,” comments Paolo Patri, Chief Technology Officer at Stevanato Group. “With the resources and experience of both companies, we will provide diabetic patients with a product that is easy-to-use, aesthetically appealing, and cost-effective.”

“We are delighted to be announcing this partnership,” says Uri Baruch, CDP’s Head of Drug Delivery. “Stevanato Group is well-established in the device field as a leading supplier of cartridges and assembly equipment for pen-injectors. It is a pleasure to extend our existing working relationship with them for their pen-injector and to address the needs of patients.”

This new collaboration is one of the programs behind the recent substantial growth of CDP’s team of healthcare-focused designers and engineers in both Cambridge (UK) and Raleigh, NC (USA) facilities. “This is another strong vote of confidence in CDP. We look forward for this to be the first of many end-to-end projects that we can be working on in this new partnership”, says Uri Baruch.


About Stevanato Group: 

Established in 1949, Stevanato Group is the world’s largest, privately-owned designer and producer of glass primary packaging for the pharmaceutical industry. From its outset, the Group has developed its own glass converting technology to ensure the highest standards of quality. The Group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly, and packaging equipment. The Group also provides analytical and testing services to study container closure integrity and integration into drug delivery devices, streamlining the drug development process. Thanks to its unique approach as a one-stop-shop, Stevanato Group can offer an unprecedented set of solutions to biopharma companies for a faster time to market and a reduced total cost of ownership.

For more information, please visit


About Cambridge Design Partnership:

Cambridge Design Partnership is an employee-owned technology and product design partner, located in Cambridge (UK) and Raleigh, North Carolina (US), focused on helping clients grow their business. Over more than 20 years, some of the world’s largest and most innovative companies have trusted them with their most important product development programs. CDP provide an integrated and holistic product development capability through a highly qualified team, well equipped development labs and ISO 13485/9001 approved methods. This encompasses research and strategy, design, technology and digital innovation, product development and regulatory and manufacturing support. CDP experts are able to take combination products through a full design cycle and submission, enabling customers to launch products that are user-centric and commercially effective.

For more information, please visit


Please contact:

Steven Kaufman,

Bastiaan de Leeuw,

Press contacts

Team Lewis
Team Lewis Italy
Ph: +39 02 36531375
Team Lewis U.S.
Ph: +1 872 264 2546

Press contacts

Team Lewis